Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101929597 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KLF16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ATP2B2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNHG4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSX2IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP7D3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IARS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMCO3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LEPROT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCUN1D5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHCHD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRR11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EML1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD59 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on